Chemokine releasing particle implants for trapping circulating prostate cancer cells

Prostate cancer (PCa) is the most prevalent cancer in U.S. men and many other countries. Although primary PCa can be controlled with surgery or radiation, treatment options of preventing metastatic PCa are still limited. To develop a new treatment of eradicating metastatic PCa, we have created an in...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, YiHui, Hakamivala, Amirhossein, Li, Shuxin, Nair, Ashwin, Saxena, Ramesh, Hsieh, Jer-Tsong, Tang, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064596/
https://www.ncbi.nlm.nih.gov/pubmed/32157115
http://dx.doi.org/10.1038/s41598-020-60696-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064596/
https://www.ncbi.nlm.nih.gov/pubmed/32157115
http://dx.doi.org/10.1038/s41598-020-60696-x

Ejemplares similares